世界の創傷ケア市場動向及び予測（～2019）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKETS COVERED 25
1.3 STAKEHOLDERS 27
1.4 SCOPE OF THE REPORT 28
1.5 RESEARCH METHODOLOGY 28
1.5.1 MARKET SIZE ESTIMATION 30
1.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 32
1.5.3 MARKET SHARE CALCULATION 33
1.5.4 KEY DATA FROM PRIMARY SOURCES 34
1.5.5 KEY DATA FROM SECONDARY SOURCES 35
1.5.6 ASSUMPTIONS 36
2 EXECUTIVE SUMMARY 37
3 MARKET OVERVIEW 41
3.1 INTRODUCTION 42
3.2 TYPES OF WOUNDS 43
3.2.1 SKIN ULCERS 46
3.2.1.1 Pressure or Decubitus Ulcers 46
3.2.1.2 Diabetic Ulcers or Neuropathic Ulcers 48
3.2.1.3 Arterial Ulcers 49
3.2.1.4 Venous Ulcers 49
3.2.2 BURNS 50
3.2.2.1 Fire/Flame Injuries 51
3.2.2.2 Scald Injuries 51
3.2.2.3 Thermal Injuries 51
3.2.2.4 Chemical Injuries 52
3.2.2.5 Electrical Injuries 52
3.2.2.6 Classification by Depth of Burn 52
3.2.2.6.1 First-degree burns (Superficial burns) 53
3.2.2.7 Superficial Partial- thickness burns (Second degree) 53
3.2.2.7.1 Deep partial-thickness burns 54
3.2.2.7.2 Full-thickness burns (third and fourth degree) 54
3.2.3 SURGICAL WOUNDS 55
3.2.3.1 Trauma Wounds 55
3.3 MARKET SEGMENTATION 56
3.4 MARKET DYNAMICS 58
3.4.1 MARKET DRIVERS 58
3.4.1.1 Rapid growth in aging population—an impetus for growth of the wound care market 58
3.4.1.2 Rising incidences of diabetes to spur market growth 58
3.4.1.3 Technological advancements to boost market growth 59
3.4.1.4 Government initiatives likely to propel the wound care market 59
3.4.1.5 Rising awareness of new technologies to fuel the market growth 60
3.4.2 MARKET RESTRAINTS 60
3.4.2.1 High costs of technologically advanced products likely to hinder market growth 60
3.4.3 MARKET OPPORTUNITIES 61
3.4.3.1 Asia presents significant growth opportunities 61
3.4.3.2 Healthy growth in the active wound care market 62
3.4.3.3 Acquisitions to open an array of opportunities for the market to flourish 62
3.4.4 MARKET CHALLENGES 63
3.4.4.1 Survival of small players & new entrants 63
3.5 GLOBAL WOUND CARE MARKET, BY END USER 64
3.6 MARKET SHARE ANALYSIS 66
3.6.1 NEGATIVE PRESSURE THERAPY (NPWT) DEVICES MARKET 66
3.6.2 ADVANCED WOUND CARE PRODUCTS MARKET 67
3.6.3 ACTIVE WOUND CARE PRODUCTS MARKET 69
3.6.4 TRADITIONAL & BASIC WOUND CARE PRODUCTS MARKET 70
4 GLOBAL WOUND CARE MARKET, BY PRODUCT 72
4.1 INTRODUCTION 73
4.2 TRADITIONAL WOUND CARE 78
4.2.1 INTRODUCTION 78
4.2.2 WOUND CLOSURE PRODUCTS 82
4.2.3 TISSUE ADHESIVES, SEALANTS, & GLUES 86
4.2.3.1 Fibrin-based Sealants 91
4.2.3.2 Collagen-based Sealants 94
4.2.3.3 Synthetic Adhesives/Glues 98
4.2.4 ANTI-INFECTIVE DRESSINGS 101
4.3 BASIC WOUND CARE 105
4.3.1 TAPES 109
4.3.2 DRY DRESSINGS 113
4.3.3 CLEANSING AGENTS 118
4.4 ADVANCED WOUND CARE 123
4.4.1 FOAM DRESSINGS 128
4.4.2 HYDROCOLLOID DRESSINGS 131
4.4.3 HYDROGEL DRESSINGS 135
4.4.4 FILM DRESSINGS 138
4.4.5 COLLAGEN DRESSINGS 142
4.4.6 ALGINATE DRESSINGS 146
4.4.7 SUPERABSORBER DRESSINGS 150
4.5 ACTIVE WOUND CARE 154
4.5.1 ARTIFICIAL SKIN & SKIN SUBSTITUTES 156
4.6 THERAPY DEVICES 164
4.6.1 INTRODUCTION 164
4.6.2 NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES 168
4.6.3 PRESSURE RELIEF DEVICES 172
4.6.4 ELECTRICAL STIMULATION (ES) DEVICES 176
4.6.5 ULTRAVIOLET (UV) DEVICES 180
4.6.6 OXYGEN & HYPERBARIC OXYGEN EQUIPMENT 183
4.6.7 WHIRLPOOL THERAPY DEVICES 187
4.6.8 ELECTROMAGNETIC THERAPY DEVICES 190
4.6.9 ULTRASOUND DEVICES 193
5 GLOBAL WOUND CARE MARKET, BY GEOGRAPHY 197
5.1 INTRODUCTION 198
5.2 NORTH AMERICA 199
5.2.1 RISING NUMBER OF ELDERLY POPULATION TO BOLSTER THE GROWTH OF THE MARKET 200
5.2.2 U.S. 207
5.2.2.1 Rising incidences of acute and chronic wound to propel the market growth 207
5.2.2.2 Changes in the reimbursement policy, an impetus for growth of cost-effective wound care products 207
5.2.2.3 Government support to trigger market growth 208
5.2.3 CANADA 216
5.2.3.1 Venture capitalist investments to drive the growth of the market 216
5.2.3.2 Increasing awareness and collaboration amongst wound care players to fuel the growth of the market 216
5.3 EUROPE 224
5.3.1 EUROPEAN WOUND CARE MARKET DRIVEN BY LARGE NUMBER OF DIABETICS IN THE REGION 225
5.3.2 GERMANY 232
5.3.2.1 Collaboration amongst players facilitates product innovation 233
5.3.3 U.K. 241
5.3.3.1 Entry of foreign companies in the U.K to propel market growth 241
5.3.3.2 Government support, an impetus for the market 241
5.3.4 FRANCE 248
5.3.4.1 Investment by prominent players in the market to drive its growth 249
5.3.5 ITALY 257
5.3.5.1 Collaborations between major players to drive the growth of the market 257
5.3.6 SPAIN 264
5.3.6.1 Conferences and seminars to create awareness regarding new wound care products 265
5.3.7 REST OF EUROPE (ROE) 271
5.3.7.1 Increasing prevalence of diabetes in the region to fuel the growth of the market 272
5.3.7.2 Investments by wound care companies in the region to trigger market growth 272
5.4 ASIA 280
5.4.1 RISE IN DIABETIC POPULATION AND CHRONIC WOUNDS TO BOOST ASIAN WOUND CARE MARKET 280
5.4.2 INVESTMENT BY PROMINENT COMPANIES IN THE ASIAN MARKET TO BOLSTER ITS GROWTH 280
5.4.3 LACK OF REIMBURSEMENT IN SOME OF THE ASIAN COUNTRIES MAY RESTRAINT THE GROWTH OF THE MARKET 281
5.5 REST OF THE WORLD (ROW) 289
5.5.1 GROWING AGING AND DIABETIC POPULATION TO DRIVE THE MARKET GROWTH 289
5.5.2 LAUNCH OF INNOVATIVE WOUND CARE PRODUCTS TO TRIGGER THE MARKET GROWTH 290
5.5.3 RISE IN THE NUMBER OF RESEARCH RELATED ACTIVITIES TO PROPEL THE GROWTH OF THE MARKET 290
6 COMPETITIVE LANDSCAPE 299
6.1 INTRODUCTION 299
6.2 NEW PRODUCT LAUNCHES 300
6.3 AGREEMENTS,PARTNERSHIPS AND COLLABORATIONS 308
6.4 ACQUISITIONS 313
6.5 EXPANSIONS 316
6.6 APPROVALS 318
7 COMPANY PROFILES 322
7.1 3M COMPANY 322
7.2 BAXTER INTERNATIONAL, INC. 328
7.3 COLOPLAST A/S 332
7.4 CONVATEC HEALTHCARE B.S.A.R.L 335
7.5 COVIDIEN PLC 341
7.6 DERMA SCIENCES, INC. 348
7.7 HOLLISTER, INC. 355
7.8 ETHICON, INC.
(SUBSIDARY OF JOHNSON AND JOHNSON) 358
7.9 KINETIC CONCEPTS, INC.
(A SUBSIDIARY OF CENTAUR GUERNSEY L.P., INC.) 364
7.10 MÖLNLYCKE HEALTH CARE AB 371
7.11 SMITH & NEPHEW 380

*Details on BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCT PORTFOLIO, KEY STRATEGY, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.
8 PRODUCT PIPELINE 387
8.1 ADVANCED WOUND CARE 386
8.2 TRADITIONAL WOUND CARE 390
8.3 ACTIVE WOUND CARE 391